NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Indo Borax to Pay Rs 40 Dividend; Investing Rs 20 Cr in New 4,000 MTPA Boron Oxide Plant
Indo Borax & Chemicals has announced its 45th AGM for July 28, 2026, to approve a total dividend of Rs 40 per share, which includes a significant Rs 30 special dividend from non-core asset sales. The company reported strong FY26 performance with revenue growing 22.9% to Rs 215.45 Cr and PAT rising 18.3% to Rs 50.27 Cr. A key growth catalyst is the planned Rs 20 Cr investment in a new 4,000 MTPA Boron Oxide facility at Pithampur, aimed at higher-margin products. This follows a leadership transition after Zenrock Chemicals acquired a controlling stake.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has transitioned to new leadership under Zenrock Chemicals and is pivoting from a pure Boric Acid manufacturer to a diversified Boron chemistry player with a new Rs 20 Cr capex plan.
ஏன் இது முக்கியம்The high dividend payout (Rs 40) provides immediate yield, while the expansion into Boron Oxide (4,000 MTPA) targets higher-margin segments, potentially re-rating the stock if execution is successful.
Total Dividend: Rs 40 per shareNew Plant Capex: Rs 20 croreCapex vs Net Worth: 5.2%FY26 Revenue Growth: 22.9%New Capacity: 4,000 MTPAரெக்கார்ட் தேதி: ஜூலை 21, 2026
📅 குறுகிய காலம்The stock is likely to see positive interest leading up to the July 21 record date for the substantial Rs 40 dividend.
📈 நீண்ட காலம்The shift toward specialized boron-based solutions and international expansion in South America/South-East Asia marks a structural growth phase for the company.
⚠ அபாய எச்சரிக்கைகள்
Raw material costs represent over 50% of revenue; 10% cost spike can squeeze margins by 500 bps.
Execution risk associated with the new Pithampur facility.
👀 கவனிக்க வேண்டியவை
Investors should track the commissioning timeline of the new Boron Oxide facility and monitor if the new management (Zenrock Chemicals) can maintain the 20%+ operating margins amidst raw material price volatility.
16.89 Lakh ESOPs granted at Re 1 Exercise Price, representing ~5.2% potential dilution
Indo Borax & Chemicals Limited has granted 16,88,950 stock options to eligible employees under its ESOP 2026 plan. Each option is convertible into one equity share at an exercise price of Re 1, which is the face value and represents a significant discount to the current market price of Rs 381.1. This grant represents a potential equity dilution of approximately 5.2% of the company's current share capital. The options will vest over a period of 1 to 5 years, with an exercise period of up to 5 years from the date of vesting.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has formally granted a specific tranche of 1.69 million options under its new 2026 ESOP scheme, establishing the exercise price and vesting timeline.
ஏன் இது முக்கியம்While ESOPs are a standard tool for talent retention, the deep-discounted exercise price (Re 1 vs market price of ~Rs 381) means the company will recognize a significant non-cash compensation expense, and existing shareholders will face moderate dilution.
Options granted: 16,88,950Exercise Price: Re 1Potential Dilution: ~5.2%Vesting Period: 1 to 5 yearsFace Value: Re 1
📅 குறுகிய காலம்The market is likely to view this as a routine administrative event, though the specific dilution percentage may be noted by institutional investors.
📈 நீண்ட காலம்The ESOPs align employee interests with long-term performance over a 5-year horizon, but will gradually increase the floating stock as options are exercised.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution of ~5.2%
Impact on reported PAT due to ESOP accounting charges
Relatively low promoter holding (30.8%)
👀 கவனிக்க வேண்டியவை
Investors should monitor the impact on 'Employee Benefit Expenses' in upcoming quarterly P&L statements as the company amortizes the fair value of these options. The ~5.2% dilution is notable for a company with a relatively lower promoter holding of 30.8%.
Indo Borax FY26 PAT Grows 18% to ₹50.27 Cr; Declares Massive ₹40 Total Dividend
Indo Borax reported a strong FY26 with revenue growing 22.9% YoY to ₹215.45 crore and PAT increasing to ₹50.27 crore. The company underwent a significant management shift with Zenrock Chemicals becoming the new promoter and a new leadership team taking charge. Shareholders were rewarded with a massive total dividend of ₹40 per share (4000%), including a ₹30 special dividend funded by the sale of non-core assets. Management has provided a positive outlook with a revenue target of ₹250+ crore for FY27.
முக்கிய அம்சங்கள்
Q4 FY26 PAT surged 41.9% YoY to ₹14.53 crore with PAT margins improving by 250 bps to 21.5%.Declared a total dividend of ₹40 per share for FY26, including a ₹30 special dividend from non-core asset sales.Maintains a dominant 50% market share in the Indian Boric Acid market and operates with near-zero debt.Revenue guidance for FY27 set at ₹250+ crore, driven by capacity debottlenecking and expansion in the DOT segment.Successful transition to new promoter Zenrock Chemicals and a new leadership team led by CEO Suresh Kalra.
👀 கவனிக்க வேண்டியவை
Investors should take note of the significant value unlocking through the special dividend and the new management's aggressive growth targets. Monitor the upcoming CAPEX announcements and the company's ability to scale the high-margin DOT and IP-grade segments.
Indo Borax FY26 PAT Up 18% to ₹50.27 Cr; Announces ₹40 Total Dividend per Share
Indo Borax & Chemicals Limited reported a strong financial performance for FY26, with consolidated revenue growing 22.9% YoY to ₹215.45 Cr and PAT increasing 18.3% to ₹50.27 Cr. The company maintained a healthy EBITDA margin of 20.5% and remains a zero-debt entity with a dominant 50% market share in the domestic Boric Acid market. A major ownership transition was completed in January 2026, where institutional investors led by Zenrock Chemicals acquired a 50.80% controlling stake. To reward shareholders, the board announced a total dividend of ₹40 per share, including a ₹30 special dividend.
முக்கிய அம்சங்கள்
Consolidated FY26 revenue increased 22.9% YoY to ₹215.45 Cr, while Q4FY26 revenue grew 25.7% YoY.Full-year PAT rose 18.3% to ₹50.27 Cr, with Q4FY26 PAT showing a significant jump of 41.9% YoY to ₹14.53 Cr.Announced a substantial dividend payout of ₹40 per share (₹10 final + ₹30 special) on a face value of ₹1.Institutional investors acquired a 50.80% controlling stake in January 2026, signaling a strategic management transition.Maintained zero-debt status and a strong market position with 20,000 MTPA Boric Acid capacity.
👀 கவனிக்க வேண்டியவை
The massive dividend payout and entry of institutional promoters are strong positive catalysts for the stock. Investors should monitor the new leadership's execution of expansion strategies and operational optimizations.
Indo Borax FY26 Revenue Rises 23% to ₹215.45 Cr; Earnings Call Set for June 2
Indo Borax & Chemicals Limited has announced its earnings call for June 2, 2026, following a strong financial performance in FY26. The company reported a 22.9% increase in consolidated operating revenue, reaching ₹215.45 crore compared to ₹175.26 crore in FY25. Consolidated Profit After Tax (PAT) also grew significantly to ₹50.27 crore from ₹42.51 crore in the previous year. The management team, including the MD and CFO, will discuss these results and future outlook during the scheduled call.
முக்கிய அம்சங்கள்
Consolidated Operating Revenue grew 22.9% YoY to ₹215.45 crore in FY26.Consolidated PAT increased by 18.2% YoY to ₹50.27 crore for the full year.Earnings conference call scheduled for June 2, 2026, at 4:00 PM IST.Company maintains a strong market position as a leading manufacturer of boron-based chemicals with 45+ years of expertise.Management representation includes MD & CEO Suresh Katra and CFO Shashikant Bharuka.
👀 கவனிக்க வேண்டியவை
Investors should attend or review the earnings call transcripts to understand the drivers behind the 18% PAT growth and management's guidance on boron chemical demand. The stock remains a watch for those interested in niche chemical manufacturers with consistent profitability.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Indo Borax Declares ₹40 Total Dividend; FY26 Revenue Up 23% YoY to ₹215.45 Cr
Indo Borax & Chemicals Limited reported a strong financial performance for FY26, with revenue from operations growing 23% to ₹215.45 crore. The board recommended a massive total dividend of ₹40 per share, which includes a ₹10 final dividend and a ₹30 special dividend. Profit before tax increased to ₹65.81 crore, supported by an exceptional gain of ₹10.15 crore. Investors should note the ongoing NCLT proceedings regarding a ₹5.09 crore inter-corporate deposit which remains unprovided for.
முக்கிய அம்சங்கள்
Total dividend of ₹40 per share (4000% of face value), including a ₹30 special dividend.Annual Revenue from Operations increased 23% YoY to ₹215.45 crore from ₹175.26 crore.Profit Before Tax (PBT) rose to ₹65.81 crore for FY26 compared to ₹57.83 crore in FY25.Exceptional gain of ₹10.15 crore recorded during the financial year.Company is pursuing recovery of a ₹5.09 crore inter-corporate deposit through NCLT; no interest is being recognized.
👀 கவனிக்க வேண்டியவை
The significant special dividend makes the stock highly attractive for income-seeking investors, while the underlying revenue growth shows business strength. Investors should maintain a watch on the NCLT outcome for the outstanding loan recovery.
Indo Borax FY26 Profit Rises to ₹65.8 Cr; Announces Total Dividend of ₹40 Per Share
Indo Borax & Chemicals reported a strong performance for FY26, with annual revenue from operations growing 23% to ₹215.45 crore. The company has rewarded shareholders with a massive total dividend of ₹40 per share, which includes a ₹10 final dividend and a ₹30 special dividend. Profit before tax increased to ₹65.81 crore from ₹57.83 crore in the previous fiscal year. Investors should note an emphasis of matter regarding a ₹5.09 crore inter-corporate deposit currently under NCLT proceedings for recovery.
முக்கிய அம்சங்கள்
Revenue from operations grew 23% YoY to ₹215.45 crore in FY26 compared to ₹175.26 crore in FY25.Total dividend of ₹40 per share declared (4000% of face value), including a ₹30 special dividend.Profit before tax (PBT) rose to ₹65.81 crore in FY26 from ₹57.83 crore in FY25.Exceptional items for the year contributed ₹10.15 crore to the bottom line.Company is pursuing recovery of a ₹5.09 crore loan through NCLT, with no interest being recognized currently.
👀 கவனிக்க வேண்டியவை
The significant special dividend makes this a highly positive outcome for yield-seeking investors, though it is likely a one-time event. Long-term investors should monitor the company's ability to maintain revenue growth and the resolution of the NCLT recovery case.
Indo Borax Shareholders Approve ESOP 2026 and Increased Investment Limits
Indo Borax & Chemicals Limited has successfully passed four key resolutions via postal ballot with overwhelming majority support. Shareholders approved the implementation of the 'ESOP 2026' plan and the grant of options exceeding 1% of issued capital to specific employees. Additionally, the company received approval to exceed statutory limits for investments, loans, and guarantees under Section 186 of the Companies Act, providing greater financial flexibility. A resolution for paying commissions to non-executive directors was also passed with nearly 100% support.
முக்கிய அம்சங்கள்
Implementation of 'ESOP 2026' approved with 99.31% of votes in favor.Shareholders authorized investments, loans, and guarantees exceeding Section 186 limits with 99.31% approval.Approval granted for ESOP allocations exceeding 1% of issued capital to identified employees.Total of 1.71 crore votes were polled, representing approximately 53.27% of the total shareholding.Remuneration via commission for non-executive directors approved with a 99.99% majority.
👀 கவனிக்க வேண்டியவை
The approval of ESOPs and higher investment limits suggests a focus on talent retention and potential capital deployment for growth. Investors should monitor future disclosures to see how the expanded investment limits are utilized for strategic purposes.
Indo Borax Shareholders Approve Suresh Kalra as MD & CEO with 99.29% Votes
Indo Borax & Chemicals Limited has announced the results of its postal ballot, where shareholders approved eight key resolutions regarding board restructuring. Most significantly, Mr. Suresh Kalra was appointed as the Managing Director and CEO with 99.29% of the votes in favor. Mr. Harsh Malhotra was also appointed as an Executive Director with similar support. The board has been further strengthened by the appointment of three new Independent Directors, all receiving over 99.99% approval, indicating strong shareholder consensus for the new leadership.
முக்கிய அம்சங்கள்
Appointment of Mr. Suresh Kalra as MD & CEO approved with 1,66,45,231 votes in favor (99.29%)Mr. Harsh Malhotra appointed as Executive Director with 99.29% support from voting shareholdersThree Independent Directors and one Non-Executive Director appointed with near-unanimous 99.99% supportA total of 8 resolutions were passed via postal ballot conducted between March 17 and April 15, 2026The leadership transition is backed by a significant majority of both promoter and public institutional shareholders
👀 கவனிக்க வேண்டியவை
The overwhelming support for the new MD and CEO suggests high investor confidence in the leadership transition. Shareholders should monitor the company's strategic direction and operational performance under the new management team.
Indo Borax to Implement ESOP 2026 Plan for Grant of 16.89 Lakh Equity Shares
Indo Borax & Chemicals Limited has issued a postal ballot notice to seek shareholder approval for the introduction of the 'ESOP 2026' scheme. The plan proposes to grant up to 16,88,950 stock options, which are convertible into an equal number of equity shares of Re. 1 face value each. The scheme is designed to attract and retain talent through equity-based incentives for eligible employees and directors. The remote e-voting period for shareholders is set from April 9, 2026, to May 8, 2026, with final results to be declared by May 12, 2026.
முக்கிய அம்சங்கள்
Proposed issuance of up to 16,88,950 Employee Stock Options (ESOPs) under the 2026 Plan.Each option is convertible into one equity share of face value Re. 1/- upon exercise.The scheme will be implemented via a direct route involving fresh allotment of shares.Remote e-voting period is scheduled from April 9, 2026, to May 8, 2026, with a cut-off date of April 3, 2026.Promoters and Independent Directors are excluded from participating in the ESOP scheme.
👀 கவனிக்க வேண்டியவை
Investors should note the potential minor equity dilution and monitor the final approval of the resolution. This is generally a positive move for long-term management stability and employee alignment.
Indo Borax Appoints Suresh Kalra as MD & CEO with ₹7 Crore Annual Pay Package
Indo Borax & Chemicals is seeking shareholder approval via postal ballot for the appointment of Mr. Suresh Kalra as Managing Director and CEO for a five-year term effective January 23, 2026. The proposed compensation package is substantial, featuring a fixed salary of ₹3.50 crore and a performance-linked bonus of up to ₹3.50 crore tied to EBITDA targets. Furthermore, the appointee is eligible for ESOPs representing up to 5% of the company's fully diluted capital base. Shareholders can cast their votes electronically between March 17 and April 15, 2026.
முக்கிய அம்சங்கள்
Appointment of Suresh Kalra as MD & CEO for a 5-year tenure starting January 23, 2026Fixed annual salary set at ₹3.50 crore with performance-based annual incrementsPerformance bonus of up to ₹3.50 crore linked to achieving specific EBITDA targetsEligibility for equity-linked incentives (ESOPs) up to 5% of the fully diluted capital baseRemote e-voting period scheduled from March 17, 2026, to April 15, 2026
👀 கவனிக்க வேண்டியவை
Investors should support the leadership transition but monitor the 5% potential equity dilution from ESOPs and track if the high compensation leads to improved EBITDA performance.
Indo Borax Appoints Shashikant Bharuka as CFO Effective March 6, 2026
Indo Borax & Chemicals Limited has appointed Mr. Shashikant Bharuka as its new Chief Financial Officer, effective March 6, 2026. Mr. Bharuka is a seasoned professional with over 24 years of post-qualification experience as a CA and CS. He has previously held significant financial roles at major listed pharmaceutical companies including Lupin, Unichem Laboratories, and Ajanta Pharma. This appointment is expected to strengthen the company's financial governance and reporting frameworks.
முக்கிய அம்சங்கள்
Mr. Shashikant Bharuka appointed as CFO and Key Managerial Personnel effective March 6, 2026Brings over 24 years of experience in finance, accounts, and tax compliance from public listed companiesPreviously served 9 years at Unichem Laboratories managing audits and consolidation of foreign subsidiariesProfessional background includes roles at Lupin Limited, Ajanta Pharma, and IPCA LaboratoriesThe Board approved the appointment following recommendations from the Audit and Nomination committees
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive step towards professionalizing management with an experienced industry veteran. Monitor the company's financial reporting and capital allocation strategies following his transition into the role.
Indo Borax Promoters to Complete 50.80% Stake Sale on Jan 23, 2026
Indo Borax & Chemicals has announced that its promoter group will complete the sale of a 50.80% stake in the company on January 23, 2026. The transaction involves the transfer of 1,63,00,230 equity shares to a consortium including Zenrock Chemicals Private Limited and India Special Assets Fund III. Upon completion, the existing promoters will cease to be in control and will be de-classified from the promoter group. This significant change in ownership marks a major transition for the company's management and strategic oversight.
முக்கிய அம்சங்கள்
Transfer of 1,63,00,230 equity shares representing 50.80% of total paid-up capitalTransaction completion date finalized as January 23, 2026, via a new SPA Letter AgreementPurchasers include Zenrock Chemicals and multiple India Special Assets/Situation FundsCurrent promoters to be de-classified and will lose control of the company post-transferThe company itself is not a party to the SPA Letter Agreement but is facilitating the disclosure
👀 கவனிக்க வேண்டியவை
Investors should closely monitor the incoming management's strategic plans and any potential open offer implications. The shift from a family-led promoter group to institutional and private equity ownership could lead to significant changes in operational focus.
Zenrock Chemicals Acquires 50.80% Stake in Indo Borax; Becomes New Promoter
Zenrock Chemicals Private Limited, along with India Special Assets Fund III and other purchasers, has completed the acquisition of 1,63,00,230 equity shares of Indo Borax & Chemicals Limited, representing a 50.80% stake. Following this transfer on January 23, 2026, the Acquirer has taken control of the company and is now classified as the new promoter. The erstwhile promoters, including Mr. Sajal Sushilkumar Jain and others, have exited their holdings and have been de-classified from the promoter group. An open offer for an additional 26.00% stake (83,43,400 shares) is also being undertaken for public shareholders.
முக்கிய அம்சங்கள்
Acquisition of 1,63,00,230 equity shares representing 50.80% of the total paid-up equity capital.Zenrock Chemicals and associated funds have officially become the new promoters of the company.The transaction was completed on January 23, 2026, following a Share Purchase Agreement dated December 15, 2025.An Open Offer is being conducted to acquire up to 83,43,400 additional shares (26.00% stake) from public shareholders.The former promoter group has been entirely de-classified as they no longer hold shares or exercise control.
👀 கவனிக்க வேண்டியவை
Investors should closely monitor the Open Offer price and the strategic roadmap provided by the new management, Zenrock Chemicals. A change in control by institutional funds often leads to professionalization and potential re-rating of the company.
Indo Borax Q3 FY26 Net Profit Rises 2.2% YoY to ₹9.27 Cr; Revenue Up 9.3%
Indo Borax & Chemicals reported a steady year-on-year performance for Q3 FY26, with consolidated revenue growing 9.3% to ₹41.02 crore. Consolidated net profit saw a marginal increase of 2.2% YoY, reaching ₹9.27 crore. The company experienced a significant sequential (QoQ) decline in performance because its Pithampur plant was shut down for 40 days (Oct 14 to Nov 22, 2025) for planned maintenance. Additionally, the company recognized a one-time benefit of ₹27.97 lakhs due to adjustments related to the New Labour Codes.
முக்கிய அம்சங்கள்
Consolidated Revenue from Operations increased 9.3% YoY to ₹41.02 crore from ₹37.51 crore.Consolidated Net Profit grew 2.2% YoY to ₹9.27 crore, while EPS stood at ₹2.89.Pithampur plant shutdown for 40 days for boiler maintenance led to a ~29% QoQ revenue decline.Nine-month consolidated net profit reached ₹35.74 crore, up from ₹32.26 crore in the previous year.One-time decrease in employee benefit provision of ₹27.97 lakhs recognized due to New Labour Codes.
👀 கவனிக்க வேண்டியவை
The sharp sequential decline is attributable to a one-off plant maintenance shutdown rather than a loss of demand. Investors should monitor Q4 results to ensure production levels and margins return to normal operating capacity.
Zenrock Chemicals and Edelweiss Funds Launch Open Offer for 26% of Indo Borax at ₹256.30/Share
Zenrock Chemicals Private Limited, along with Edelweiss-backed funds, has issued a Draft Letter of Offer (DLOF) to acquire a 26% stake in Indo Borax & Chemicals Limited. The open offer is priced at ₹256.30 per share, targeting the acquisition of up to 83,43,400 equity shares. This mandatory offer follows the initial announcement in mid-December 2025 and is triggered by substantial acquisition regulations. The tendering period for public shareholders is tentatively scheduled to open on February 6, 2026.
முக்கிய அம்சங்கள்
Open offer price fixed at ₹256.30 per equity share of face value ₹1 eachAcquisition target of 83,43,400 shares representing 26% of the company's voting share capitalAcquirers include Zenrock Chemicals and three Edelweiss-managed Alternative Investment Funds (PACs)The total offer is payable in cash and is not subject to any minimum level of acceptanceTentative schedule sets the offer opening date for February 6, 2026, and closing on February 19, 2026
👀 கவனிக்க வேண்டியவை
Investors should compare the offer price of ₹256.30 against the current market price to evaluate the premium or discount. It is advisable to wait for the recommendation of the Committee of Independent Directors, due by February 4, 2026, before deciding to tender shares.
Zenrock Chemicals and PACs Launch Open Offer for 26% Stake in Indo Borax at ₹162/Share
Zenrock Chemicals Private Limited, along with India Special Assets Fund III and other PACs, has announced an open offer to acquire up to 83,43,400 equity shares of Indo Borax & Chemicals Limited. This represents 26% of the company's voting share capital. The offer price is set at ₹162 per share, to be paid in cash, following a substantial acquisition agreement. This move indicates a significant change in the shareholding structure and potential management control of the company.
முக்கிய அம்சங்கள்
Open offer to acquire up to 83,43,400 equity shares, representing 26% of the total voting capital.Offer price fixed at ₹162 per equity share, payable in cash.Acquirers include Zenrock Chemicals Private Limited and three India Special Assets Funds (PACs).The offer is triggered under Regulations 3(1) and 4 of SEBI (SAST) Regulations, 2011.IIFL Capital Services Limited is acting as the Manager to the Open Offer.
👀 கவனிக்க வேண்டியவை
Investors should monitor the market price relative to the ₹162 offer price to determine if tendering shares is beneficial. The involvement of special situation funds suggests a potential strategic turnaround or value unlocking that warrants a close watch on future management commentary.
Zenrock Chemicals to Acquire 50.8% Stake in Indo Borax; Open Offer Launched at ₹256.30
Zenrock Chemicals Private Limited, along with three Special Assets Funds, has entered into a Share Purchase Agreement to acquire a 50.80% controlling stake in Indo Borax & Chemicals Limited from its current promoters. This transaction has triggered a mandatory open offer for an additional 26% stake (83,43,400 shares) from public shareholders at a price of ₹256.30 per share. The total consideration for the open offer is approximately ₹213.84 crores, while the initial promoter stake acquisition is valued at ₹417.77 crores. The acquirers have stated their intention to maintain the company's listed status following the completion of the offer.
முக்கிய அம்சங்கள்
Acquisition of 1,63,00,230 equity shares (50.80% stake) from existing promoters at ₹256.30 per share.Mandatory Open Offer launched for 83,43,400 shares (26.00% stake) at the same price of ₹256.30.Total transaction value including the Open Offer is estimated at approximately ₹631.61 crores.Acquirers include Zenrock Chemicals and three PACs: India Special Assets Fund III, ISAF III Onshore Fund, and Special Situation India Fund.The offer price of ₹256.30 will be paid entirely in cash to validly tendering public shareholders.
👀 கவனிக்க வேண்டியவை
Investors should monitor the stock's market price relative to the ₹256.30 offer price; if the market price remains significantly lower, tendering in the open offer may be beneficial. Long-term holders should evaluate the track record of the new incoming promoters and their strategic vision for the company's chemical business.
INDOBORAX: Promoter Group to Sell 50.80% Stake, Open Offer Triggered
Indo Borax & Chemicals Limited announced that its promoter group will sell an aggregate of 1,63,00,230 equity shares, constituting approximately 50.80% of the total paid-up equity share capital, to Zenrock Chemicals Private Limited, India Special Assets Fund III, ISAF III Onshore Fund, and Special Situation India Fund. This transaction triggers an open offer for acquisition of an additional 26% of the expanded voting share capital, in accordance with SEBI regulations. The per share price for the sale is INR 256.30. Upon completion, the sellers will be de-classified from being promoters.
முக்கிய அம்சங்கள்
Promoter group to sell 50.80% stake in INDOBORAX.Open offer triggered for an additional 26% of the expanded voting share capital.Sale involves 1,63,00,230 equity shares.Per share price for the sale is INR 256.30.Sellers will be de-classified from promoter group after the transaction.
👀 கவனிக்க வேண்டியவை
Investors should closely monitor the open offer details and evaluate whether to participate, considering the offer price and their investment strategy. Keep an eye on the new management's strategy post-acquisition.
Indo Borax executes framework agreement for property sale to promoter group
Indo Borax & Chemicals Limited has executed a framework agreement on December 13, 2025, with Mr. Sajal Sushilkumar Jain, Mrs. Sreelekha Sajal Jain, and Mrs. Pranika Saumya Jain for the sale and transfer of certain immovable properties and vehicles. The Purchasers collectively hold approximately 32.82% of the total share capital of the company and are members of the promoter group. This transaction, approved by the audit committee, board of directors, and shareholders, falls within related party transactions and is at arm's length. The agreement records terms for transferring residential property to Sajal Sushilkumar Jain and Sreelekha Sajal Jain, and identified vehicles to all three purchasers.
முக்கிய அம்சங்கள்
Framework Agreement executed on December 13, 2025Purchasers collectively hold approximately 32.82% of the company's share capitalTransaction involves sale of immovable properties and vehiclesApproved by shareholders on August 26, 2025 via postal ballot
👀 கவனிக்க வேண்டியவை
Investors should monitor the progress of the property and vehicle sale and assess its impact on the company's financials. Be aware that this transaction is with related parties.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
